Prima BioMed Activates Study Sites in Germany and Multiple European Countries for "CANVAS" Clinical Trial

SYDNEY, AUSTRALIA -- (Marketwired) -- 07/03/13 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima", the "Company") is pleased to announce that it has activated a substantial number of additional clinical trial sites in Belgium, Bulgaria, Germany, Lithuani ...